Phase 3 study of first-line crizotinib vs pemetrexed−cisplatin/carboplatin (PCC) in East Asian patients (pts) with ALK+ advanced non-squamous non-small cell lung cancer (NSCLC).

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 9058-9058 ◽  
Author(s):  
Shun Lu ◽  
Tony Mok ◽  
You Lu ◽  
Jianying Zhou ◽  
Yuankai Shi ◽  
...  
2021 ◽  
Vol 16 (3) ◽  
pp. S562-S563
Author(s):  
H. Feng ◽  
C. Xu ◽  
W. Wang ◽  
D. Wang ◽  
Y. Zhu ◽  
...  

2021 ◽  
Vol 16 (10) ◽  
pp. S1214
Author(s):  
B. Song ◽  
C. Xu ◽  
W. Wang ◽  
D. Wang ◽  
Y. Zhu ◽  
...  

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 9022-9022 ◽  
Author(s):  
Koichi Goto ◽  
James Chih-Hsin Yang ◽  
Dong-Wan Kim ◽  
Shun Lu ◽  
Takashi Seto ◽  
...  

2010 ◽  
Vol 5 (10) ◽  
pp. 1609-1615 ◽  
Author(s):  
Tony Mok ◽  
Yi-long Wu ◽  
Joseph Siu-kie Au ◽  
Caicun Zhou ◽  
Li Zhang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document